Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.25%
1,104.10
+2.73
+0.25%
1,101.371,103.631,105.311,091.41
SIXC
Communications
SIXC
Communications
SIXC
-1.50%
604.16
-9.19
-1.50%
613.35613.35613.35601.49
SIXE
Energy
SIXE
Energy
SIXE
-0.09%
1,197.81
-1.02
-0.09%
1,198.831,199.681,199.751,182.41
SIXI
Industrials
SIXI
Industrials
SIXI
-0.88%
1,740.41
-15.54
-0.88%
1,755.951,754.061,756.031,734.69
SIXM
Financials
SIXM
Financials
SIXM
-0.64%
634.44
-4.07
-0.64%
638.51637.41637.41633.05
SIXR
Staples
SIXR
Staples
SIXR
-0.31%
840.90
-2.62
-0.31%
843.52843.35846.40837.93
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.38%
215.13
-0.82
-0.38%
215.95215.95216.84215.06
SIXT
Technology
SIXT
Technology
SIXT
+2.86%
3,228.71
+89.80
+2.86%
3,138.913,189.303,230.853,174.76
SIXU
Utilities
SIXU
Utilities
SIXU
+0.16%
935.87
+1.50
+0.16%
934.37934.72938.26927.50
SIXV
Health care
SIXV
Health care
SIXV
-1.37%
1,457.12
-20.31
-1.37%
1,477.431,474.121,474.121,451.80
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.83%
2,399.84
+19.65
+0.83%
2,380.192,389.342,403.042,380.47
URGN:NASDAQ
Urogen Pharma Ltd
$24.11
-0.82%
(-0.20) 1D
$24.11
0.00% (0.00)
After hours
Closed: Apr 24, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for URGN...
Open
$24.56
High
$24.60
Low
$23.79
Mkt. cap
1.17B
Avg. vol.
734.35K
Volume
585.36K
52-wk high
$29.98
52-wk low
$3.42
EPS
-$3.19
Beta
1.43
Shares outstanding
48.68M
No. of employees
291
News stories
From sources across the web
About Urogen Pharma Ltd
CEO-
Employees291
Founded2004
HeadquartersNew York, New York, United States
SectorBiotechnology
Websiteurogen.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
20.25M
24.22M
27.48M
37.84M
Cost of goods sold
2.33M
3.55M
3.28M
3.29M
Cost of revenue
2.33M
3.55M
3.28M
3.29M
Research and development expenses
19.87M
18.91M
14.01M
14.31M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
34.97M
43.20M
37.58M
39.35M
Operating expense
54.84M
62.11M
51.59M
53.66M
Total operating expenses
57.17M
65.66M
54.87M
56.95M
Operating income
-36.91M
-41.45M
-27.39M
-19.12M
Other non operating income
-4.67M
-5.02M
-4.82M
-4.66M
EBT including unusual items
-43.45M
-48.92M
-34.40M
-26.64M
EBT excluding unusual items
-43.45M
-48.92M
-34.40M
-26.64M
Income tax expense
392.00K
1.02M
-1.05M
-275.00K
Effective tax rate
-0.90%
-2.07%
3.06%
1.03%
Other operating expenses
-
-
-
-
Net income
-43.84M
-49.94M
-33.35M
-26.36M
Net profit margin
-216.47%
-206.24%
-121.34%
-69.68%
Earnings per share
-0.92
-1.05
-0.69
-0.53
Interest and investment income
2.20M
1.68M
1.18M
908.00K
Interest expense
-4.07M
-4.13M
-3.37M
-3.77M
Net interest expenses
-1.86M
-2.46M
-2.20M
-2.86M
Depreciation and amortization charges
-
-
-
-
EBITDA
-36.84M
-41.37M
-26.40M
-19.04M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more